Noninvasive transcranial alternating current stimulation (tACS) may lead to rapid improvement in major depressive disorder (MDD), results of a randomized, sham-controlled trial suggested. However, ...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has ...
Please provide your email address to receive an email when new articles are posted on . Researchers analyzed 58 individuals with aphasia given transcranial direct current stimulation or sham treatment ...
Please provide your email address to receive an email when new articles are posted on . Anodal transcranial direct current stimulation, with exercise and patient education, improved disability caused ...
Historic FDA approval: Flow FL-100 becomes the first FDA-approved at-home brain stimulation device for moderate to severe ...